CLOs on the Move

Ridgewood Nursing Ctr

www.genesiseldercare.com

 
Ridgewood Nursing Ctr is a Bedford, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Absorption Systems

Absorption Systems is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Exton, PA. To find more information about Absorption Systems, please visit www.absorption.com

Liberty Communications Network

Liberty Communications Network is a East Windsor, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CareMax

CareMax Medical Centers are Medicare Advantage facilities with a full complement of health and wellness services for the senior population.

Nava Health

Nava Health is a vertically integrated, tech-enabled healthcare practice that combines integrative, functional, preventive, and regenerative medicine to optimize health and increase longevity.

Kymera Therapeutics

Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.